SCHEMBL3765836

SCHEMBL3765836

Clc1nc(N2CCCCC2)ns1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.41
USP2 O75604 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HTT P42858 1/20 0.38
RECQL P46063 1/20 0.38
ATM Q13315 1/20 0.38
HRH1 P35367 1/20 0.38
ALDH1A1 P00352 4/20 0.36
MAPK1 P28482 3/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
TSHR P16473 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.35
GALR3 O60755 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3770598 0.98 HRH1 (0.39) SMN1; SMN2USP2TDP1MEN1KMT2A
SCHEMBL3759762 0.82 KMT2A (0.42) SMN1; SMN2TDP1MEN1KMT2AHTT
SCHEMBL3767897 0.77 SMO (0.37) MEN1KMT2AHTTLMNA
SCHEMBL3765914 0.74 HSD17B10 (0.37) SMN1; SMN2MEN1KMT2AALDH1A1MAPK1
SCHEMBL25604734 0.72 MEN1 (0.39) SMN1; SMN2USP2TDP1MEN1KMT2A
SCHEMBL27711577 0.72 KDM4E (0.51) USP2KMT2AHTTRECQLATM
Hydrochloric Acid SCHEMBL23860548 0.72 MEN1 (0.37) SMN1; SMN2USP2TDP1MEN1KMT2A
Hydrochloric Acid SCHEMBL23860461 0.72 MEN1 (0.37) SMN1; SMN2USP2TDP1MEN1KMT2A
Hydrochloric Acid SCHEMBL23860464 0.72 MEN1 (0.37) SMN1; SMN2USP2TDP1MEN1KMT2A
Hydrochloric Acid SCHEMBL25394009 0.71 USP2 (0.34) SMN1; SMN2USP2TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013031694-A1 AMINE COMPOUND AND SALT THEREOF 富山化学工業株式会社 (JP) 2013-03-07 WO disclosed
US-7851473-B2 Amide compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-14 US disclosed
US-20080312226-A1 Amide Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-18 US disclosed
CN-101103007-A Amide compound TAKEDA PHARMACEUTICAL (JP) 2008-01-09 CN disclosed
EP-1813606-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312226-A1 Amide Compound FAAH, FAAH2, CNR2 SMN1; SMN2 2454/4885USP2 1568/4885TDP1 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.